Filing Details
- Accession Number:
- 0000784199-18-000151
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-07-30 16:32:31
- Reporting Period:
- 2018-07-26
- Accepted Time:
- 2018-07-30 16:32:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 784199 | Cryolife Inc | CRY | Surgical & Medical Instruments & Apparatus (3841) | 592417093 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1653206 | E John Davis | 1655 Roberts Blvd., Nw Kennesaw GA 30144 | Senior Vp, Global Sales | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-07-26 | 3,391 | $16.30 | 56,134 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-07-26 | 3,391 | $31.00 | 52,743 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2018-07-26 | 3,391 | $16.30 | 3,391 | $16.30 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2018-02-21 | 2024-02-21 | No | 4 | M | Direct |
Footnotes
- The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on December 8, 2017.
- In a Form 4 filed on July 10, 2018, Reporting Person over reported the total number of shares beneficially owned by a de minimus number of shares. As a result, such shares were reflected in the post-transaction amounts in column 5 of that Form 4. Beneficially owned shares are hereby updated in column 5 on this Form 4 to remove such previously-added shares.
- Reflects the price of $31 the shares were sold. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at this price
- Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/21/2018
Billionaire Hedge Funds
